Human sweat metabolomics for lung cancer screening

Analytical and Bioanalytical Chemistry

Volumn 407, Issue 18, 2015, Pages 5381-5392

  Calderón Santiago, Mónica ^a   Priego Capote, Feliciano ^a   Turck, Natacha ^b   Robin, Xavier ^b   Jurado Gámez, Bernabé ^a,c   Sanchez, Jean C ^b   Luque De Castro, María D ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Biomarker panel; Human sweat; LC QTOF; Lung cancer; Mass spectrometry; Metabolomics

Indexed keywords

BIOLOGICAL ORGANS; BIOMOLECULES; DISEASES; MASS SPECTROMETRY; METABOLITES; SCREENING;

CLINICAL SAMPLES; FALSE NEGATIVES; HUMAN SWEAT; LC-QTOF; LUNG CANCER; LUNG CANCER SCREENING; METABOLITE ANALYSIS; METABOLOMICS;

DIAGNOSIS;

AGED; CHEMISTRY; COHORT ANALYSIS; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; LUNG NEOPLASMS; MALE; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SWEAT; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

AGED; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ROC CURVE; SWEAT; TANDEM MASS SPECTROMETRY;

EID: 84938063008     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-015-8700-8     Document Type: Article

References (39)

1. Álvarez-Sánchez B, Priego-Capote F, Luque de Castro MD (2010) Metabolomics analysis I. Selection of biological samples and practical aspects preceding sample preparation. TrAC Trends Anal Chem 29:111-119. doi: 10.1016/j.trac.2009.12.003
2. Mena-Bravo A, Luque de Castro MD (2014) Sweat: a sample with limited present applications and promising future in metabolomics. J Pharm Biomed Anal 90:139-147. doi: 10.1016/j.jpba.2013.10.048
3. Lynch A (2010) Thesis: Development and characterisation of solid-state ion-selective electrodes, and their application to sweat analysis for cystic fibrosis diagnosis. The Centre for Sensor Web Technologies, Dublin City University
4. Kirk JM, Keston M, McIntosh I, al Essa S (1992) Variation of sweat sodium and chloride with age in cystic fibrosis and normal populations: further investigations in equivocal cases. Ann Clin Biochem 29:145-152. doi: 10.1177/000456329202900204
5. Gibson LE, Cooke RE (1959) A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23:545-549
6. De Giovanni N, Fucci N (2013) The current status of sweat testing for drugs of abuse: a review. Curr Med Chem 20:545-561
7. Kintz P, Tracqui A, Mangin P, Edel Y (1996) Sweat testing in opioid users with a sweat patch. J Anal Toxicol 20:393-397
8. Uemura N, Nath RP, Harkey MR et al (2004) Cocaine levels in sweat collection patches vary by location of patch placement and decline over time. J Anal Toxicol 28:253-259
9. Sears ME, Kerr KJ, Bray RI (2012) Arsenic, cadmium, lead, and mercury in sweat: a systematic review. J Environ Public Health 2012:184745. doi: 10.1155/2012/184745
10. Taylor JR, Watson ID, Tames FJ, Lowe D (1998) Detection of drug use in a methadone maintenance clinic: sweat patches versus urine testing. Addiction 93:847-853
11. Lee NVL, Miller PW, Buono MJ (2010) The effect of spironolactone on sweat and urinary sodium excretion during exercise in humans. Clin Physiol Funct Imaging 30:13-16. doi: 10.1111/j.1475-097X.2009.00898.x
12. Hew-Butler T, Noakes TD, Soldin SJ, Verbalis JG (2010) Acute changes in arginine vasopressin, sweat, urine and serum sodium concentrations in exercising humans: does a coordinated homeostatic relationship exist? Br J Sports Med 44:710-715. doi: 10.1136/bjsm.2008.051771
13. Kutyshenko VP, Molchanov M, Beskaravayny P et al (2011) Analyzing and mapping sweat metabolomics by high-resolution NMR spectroscopy. PLoS ONE. doi: 10.1371/journal.pone.0028824
14. Calderón-Santiago M, Priego-Capote F, Jurado-Gámez B, Luque de Castro MD (2014) Optimization study for metabolomics analysis of human sweat by liquid chromatography-tandem mass spectrometry in high resolution mode. J Chromatogr A 1333:70-78. doi: 10.1016/j.chroma.2014.01.071
15. Ehmann R, Boedeker E, Friedrich U et al (2012) Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J 39:669-676. doi: 10.1183/09031936.00051711
16. World Health Organization (2012) WHO Cancer. Cancer fact sheet No. 297
17. Howlader N, Noone AM, Krapcho M, et al (2013) SEER Cancer Statistics Review, 1975-2010,. Natl. Cancer Institute. Bethesda, MD, http//seer.cancer.gov/csr/1975-2010/, based Novemb. 2012 SEER data submission, posted to SEER web site, April 2013
18. Wegwarth O, Schwartz LM, Woloshin S et al (2012) Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med 156:340-349. doi: 10.7326/0003-4819-156-5-201203060-00005
19. Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395-409. doi: 10.1056/NEJMoa1102873
20. Khadir A, Tiss A (2013) Proteomics approaches towards early detection and diagnosis of cancer. J Carcinog Mutagen S14:2
21. Xiao H, Zhang L, Zhou H et al (2012) Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics 11:1-12. doi: 10.1074/mcp.M111.012112
22. Fan TWM, Lane AN, Higashi RM et al (2009) Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM). Mol Cancer. doi: 10.1186/1476-4598-8-41
23. Beane J, Vick J, Schembri F et al (2011) Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Cancer Prev Res 4:803-817. doi: 10.1158/1940-6207.CAPR-11-0212
24. Girard L, Zöchbauer-Müller S, Virmani AK et al (2000) Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 60:4894-4906
25. Pleasance ED, Stephens PJ, O'Meara S et al (2010) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463:184-190. doi: 10.1038/nature08629
26. Beger R (2013) A review of applications of metabolomics in cancer. Metabolites 3:552-574. doi: 10.3390/metabo3030552
27. Kami K, Fujimori T, Sato H et al (2013) Metabolomic profiling of lung and prostate tumor tissues by capillary electrophoresis time-of-flight mass spectrometry. Metabolomics 9:444-453. doi: 10.1007/s11306-012-0452-2
28. Carrola J, Rocha CM, Barros AS et al (2011) Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res 10:221-230. doi: 10.1021/pr100899x
29. Jentzmik F, Stephan C, Miller K et al (2010) Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 58:12-18. doi: 10.1016/j.eururo.2010.01.035
30. Karlsson M, Mårild S, Brandberg J et al (2006) Serum phospholipid fatty acids, adipose tissue, and metabolic markers in obese adolescents. Obesity 14:1931-1939. doi: 10.1038/oby.2006.225
31. Sánchez de Cos J, Hernández JH, López MFJ et al (2011) SEPAR guidelines for lung cancer staging. Arch Bronconeumol 47:454-465. doi: 10.1016/j.arbres.2011.06.013
32. Robin X, Turck N, Hainard A et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77-84. doi: 10.1186/1471-2105-12-77
33. Robin X, Turck N, Hainard A et al (2013) PanelomiX: a threshold-based algorithm to create panels of biomarkers. Translant Proteomics 1:57-64. doi: 10.1016/j.trprot.2013.04.003
34. Xia J, Broadhurst DI, Wilson M, Wishart DS (2013) Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 9:280-299. doi: 10.1007/s11306-012-0482-9
35. Kim K-R, Park H-G, Paik M-J, Kim K-R, Park H-G, Paik M-J et al (1998) Gas chromatographic profiling and pattern recognition analysis of urinary organic acids from uterine myoma patients and cervical cancer patients. J Chromatogr B Biomed Sci Appl 712:11-22. doi: 10.1016/S0378-4347(98)00155-8
36. Simonsen N, van't Veer P, Strain JJ et al (1998) Adipose tissue omega-3 and omega-6 fatty acid content and breast cancer in the EURAMIC study. Am J Epidemiol 147:342-352. doi: 10.1093/oxfordjournals.aje.a009456
37. Simopoulos A (2002) The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 56:365-379. doi: 10.1016/S0753-3322(02)00253-6
38. Simopoulos AP (2008) The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 233:674-688. doi: 10.3181/0711-MR-311
39. Takeuchi T, Fujiki H, Kameya T (1981) Characterization of amylases produced by tumors. Clin Chem 27:556-559